T
Tobias V. Lanz
Researcher at Stanford University
Publications - 31
Citations - 2013
Tobias V. Lanz is an academic researcher from Stanford University. The author has contributed to research in topics: Antibody & Immunology. The author has an hindex of 10, co-authored 22 publications receiving 1186 citations. Previous affiliations of Tobias V. Lanz include University Hospital Heidelberg & German Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
Alban Bessede,Alban Bessede,Marco Gargaro,Maria Teresa Pallotta,Davide Matino,Giuseppe Servillo,Cinzia Brunacci,Silvio Bicciato,Emilia Maria Cristina Mazza,Antonio Macchiarulo,Carmine Vacca,Rossana G. Iannitti,Luciana Tissi,Claudia Volpi,Maria Laura Belladonna,Ciriana Orabona,Roberta Bianchi,Tobias V. Lanz,Michael Platten,Maria Agnese Della Fazia,Danilo Piobbico,Teresa Zelante,Hiroshi Funakoshi,Toshikazu Nakamura,David Gilot,Michael S. Denison,Gilles J. Guillemin,James B. DuHadaway,George C. Prendergast,Richard P. Metz,Michel Geffard,Louis Boon,Matteo Pirro,Alfonso Iorio,Bernard Veyret,Luigina Romani,Ursula Grohmann,Francesca Fallarino,Paolo Puccetti +38 more
TL;DR: It was found that a first exposure of mice to LPS activated the ligand-operated transcription factor aryl hydrocarbon receptor and the hepatic enzyme tryptophan 2,3-dioxygenase, which provided an activating ligand to the former, to downregulate early inflammatory gene expression, pointing to a role for AhR in contributing to host fitness.
Journal ArticleDOI
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.
Michael Platten,Sawsan Youssef,Eun Mi Hur,Peggy P. Ho,May H. Han,Tobias V. Lanz,Lori K. Phillips,Matthew J. Goldstein,Roopa Bhat,Cedric S. Raine,Raymond A. Sobel,Lawrence Steinman +11 more
TL;DR: It is observed that RAAS is up-regulated in brain lesions of MS and its animal model, experimental autoimmune encephalomyelitis, and modulation of the RAAS with inexpensive, safe pharmaceuticals used by millions worldwide is an attractive therapeutic strategy for application to human autoimmune diseases.
Journal ArticleDOI
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Tobias V. Lanz,R. Camille Brewer,Peggy P. Ho,Jae Seung Moon,Kevin Jude,Daniel Fernandez,Ricardo A. Fernandes,Alejandro M. Gomez,Gabriel-Stefan Nadj,Christopher M. Bartley,Ryan D. Schubert,Isobel A. Hawes,Sara E. Vazquez,Manasi Iyer,J. Bradley Zuchero,Bianca Teegen,Jeffrey Dunn,Christopher Lock,Lucas Kipp,Victoria C. Cotham,Beatrix Ueberheide,Blake T. Aftab,Mark E. Anderson,Joseph L. DeRisi,Michael R. Wilson,Rachael Bashford-Rogers,Michael Platten,K. Christopher Garcia,Lawrence Steinman,William H. Robinson +29 more
TL;DR: In this paper , the authors demonstrate high-affinity molecular mimicry between the EBV transcription factor EBV nuclear antigen 1 (EBNA1) and the central nervous system protein glial cell adhesion molecule (GlialCAM) and provide structural and in vivo functional evidence for its relevance.
Journal ArticleDOI
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Tobias V. Lanz,Rebeccah Brewer,Peggy P. Ho,Jae Seung Moon,Kevin Jude,Daniel Fernandez,Ricardo A. Fernandes,Alejandro M. Gomez,Gabriel-Stefan Nadj,Christopher M. Bartley,Ryan D. Schubert,Isobel A. Hawes,Sara E. Vazquez,Manasi Iyer,J. Bradley Zuchero,Bianca Teegen,Jeffrey Dunn,Christopher Lock,Lucas Kipp,Victoria C. Cotham,Beatrix Ueberheide,Blake T. Aftab,Mark E. Anderson,Joseph L. DeRisi,Michael R. Wilson,Rachael Bashford-Rogers,Michael Platten,K. Christopher Garcia,Lawrence Steinman,William H. Robinson +29 more
TL;DR: In this paper , the authors demonstrate high-affinity molecular mimicry between the EBV transcription factor EBV nuclear antigen 1 (EBNA1) and the central nervous system protein glial cell adhesion molecule (GlialCAM) and provide structural and in vivo functional evidence for its relevance.
Journal ArticleDOI
Angiotensin II sustains brain inflammation in mice via TGF-β
Tobias V. Lanz,Zhaoqing Ding,Peggy P. Ho,Jian Luo,Ankur N. Agrawal,Hrishikesh K. Srinagesh,Robert C. Axtell,Hui Zhang,Michael Platten,Tony Wyss-Coray,Tony Wyss-Coray,Lawrence Steinman +11 more
TL;DR: Ang II is identified as a paracrine mediator, sustaining inflammation in the CNS in the EAE mouse model of MS via TGF-beta, suggesting that AT1R antagonists, frequently prescribed as antihypertensives, may be useful to interrupt this proinflammatory, CNS-specific pathway in individuals with MS.